MANAGEMENT OF ARDHAVABHEDAKA (MIGRAINE) WITH AGNIKARMA AND PATHYADI KWATHA - A COMPARATIVE STUDY
- Conditions
- Ardhavbhedaka (MIGRAINE)
- Registration Number
- CTRI/2017/02/007845
- Lead Sponsor
- Govt Akhandanand Ayurveda Hospital and Smt Maniben Ayurvedic Hospital
- Brief Summary
This is a randomized, parallel group trial in Department of Shalakyatantra OPD at Government Akhandanand Ayurveda College and hospital, Ahmedabad, Gujarat.
Dealing with patients of Ardhavabhedaka(Migraine) and its treatment.
Acharya Charaka has given Agnikarma as a treatment for Ardhavabhedaka as in his opinion Ardhavabhedaka is due to vitiated vata-kapha and Acharya Sushruta has discribed agnikarma as quick pain relief and stopping the recurrence of a disease.
Therefore in the present study Agnikarma along with Pathyadi Kwatha (Orally) have been selected for clinical trials in group A.
Pathyadi Kwatha (Orally) has been selected for clinical trials in group P.
METHODS:
in group A, Agnikarma will be done on effected temporal site of Face once in a week for 4 weeks and pathyadi kwatha will be given orally in dose of 40 ml twice in a day for 30 days.
in group P, pathyadi kwatha will be given in same dose and duration as group A.
CONCLUSION
On analysing overall effect of therapies in both the group, in Group A, 2 (14.3%) patient were cured, 11 (78.6%) patients were Markedly Improved, and 1 (7.14%) patient was Moderately Improved.
 On analysing overall effect of therapies in Group P, 1 (7.14%) patient was cured while 13 (92.9%) patients were Markedly Improved.
clinically Agnikarma and Pathyadi Kwatha combine work better to manage the Ardhavabhedaka (Migraine).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 30
Patients with classical picture of Ardhavabhedaka [Migraine] will be selected irrespective of Sex, Religion and Profession.
- Patient who are not eligible for Agnikarma as per Ayurvedic Texts.
- Age < 16 years and > 70 years.
- Referred pain in one half of the head due to disorder of Eye, Ear, Nose, Throat, Teeth etc.
- will be excluded iv.
- Patient having Migraine except Migraine without Aura like Migraine with aura, Familial Hemiplegic Migraine (FHM), Complicated Migraine etc.
- Patient suffering from Diabetes, Tuberculosis, Hypertension, Malignancy and/or any other General Debilitating Health condition.
- Patient who need surgical and intervention (Polyp etc.) vii.
- Patient on any other medications which is interfering with trial treatment.
- Patients, not willing to be registered for trial.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method improvement in headache of migraine 15 days
- Secondary Outcome Measures
Name Time Method improvement in duration of onset and severity of pain in migraine headache 30 days
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Government Akhandanand Ayurveda Hospital
🇮🇳Ahmadabad, GUJARAT, India
Government Akhandanand Ayurveda Hospital🇮🇳Ahmadabad, GUJARAT, IndiaDr Brinda KanakharaPrincipal investigator9408966840bmk1490@gmail.com